Top Markets
Coin of the day
Restart Life Sciences Corp. Restart Life Sciences Corp.

Restart Life Sciences Corp.

HEAL
Rangering i aksjer #37250
Operating internationally through its various subsidiaries, Restart Life... Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spectrum disorder, the development of health-promoting foods designed for comprehensive mind and body wellness, and the execution of a psilocybin clinical trial aimed at fragile X syndrome. Founded in 2004 and based in Vancouver, Canada, the company adopted its current name in November 2024, having previously been known as Nova Mentis Life Science Corp.
Aksjekurs
$0.05137558
Sist synkronisert: 2026-08-13
Markedsverdi
$1.88M
Endring (1 dag)
0.00%
Endring (1 år)
-11.66%
Land
CA
Handel Restart Life Sciences Corp. (HEAL)

Kategori

P/S-forhold for Restart Life Sciences Corp. (HEAL)
P/S-forhold per 2026 TTM: 0
Ifølge Restart Life Sciences Corp. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for Restart Life Sciences Corp. fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
10.17 -
US
10.13 -
NL
- -
CH
- -
KR
4.74 -
BE